Background-Geriatric conditions may influence outcomes among patients receiving implantable cardioverter-defibrillators (ICDs). We sought to determine the prevalence of frailty and dementia among older adults receiving primary prevention ICDs and to determine the impact of multimorbidity on mortality within 1 year of ICD implantation. Methods and Results-The cohort included 83 792 Medicare patients from the National Cardiovascular Data Registry ICD Registry who underwent first primary prevention ICD implantation between 2006 and 2009. These data were merged with Medicare analytic files to determine the prevalence of frailty, dementia, and other conditions before ICD implantation, as well as 1-year mortality. A validated claim-based algorithm was used to identify frail patients. Mutually exclusive patterns of chronic conditions were examined. The association of each pattern with 1-year mortality was assessed using logistic regression models adjusted for selected patient characteristics. Approximately 1 in 10 Medicare patients with heart failure receiving a primary prevention ICD had frailty (10%) or dementia (1%). One-year mortality was 22% for patients with frailty, 27% for patients with dementia, and 12% in the overall cohort. Several multimorbidity patterns were associated with high 1-year mortality rates: dementia with frailty (29%), frailty with chronic obstructive pulmonary disease (25%), and frailty with diabetes mellitus (23%). These patterns were present in 8% of the cohort. Conclusions-More than 10% of Medicare beneficiaries with heart failure receiving primary prevention ICDs have frailty or dementia. These patients had significantly higher 1-year mortality than those with other common chronic conditions. Frailty and dementia should be considered in clinical decision-making and guideline development.
I mplantable cardioverter-defibrillators (ICDs) are widely used for primary prevention of sudden cardiac death in the large population of patients with systolic heart failure and left ventricular ejection fraction ≤35% who are at risk for lethal ventricular arrhythmias. Although ICDs for primary prevention effectively reduced mortality in clinical trials, subsequent observational studies found that patients with a 20% 1-year mortality risk did not clearly benefit from ICDs. 1, 2 Consequently, Medicare's coverage policy includes the important exception of patients with noncardiac diseases associated with a life expectancy <1 year. 3 More than 140 000 ICDs are implanted in the United States annually for primary prevention indications, many in older adults. 4 More than 40% of new ICD implants are in patients aged >70 years, and 10% to 20% are in patients aged >80 years, yet the mean age of patients in the major ICD trials was between 58 and 65 years. 5 Older adults with heart failure often have multiple comorbidities and are frail, increasing their risk of death from noncardiac causes. An understanding of outcomes in older patients, especially those with common comorbidities, is limited. [5] [6] [7] Measures of geriatric impairment-multifactorial, nondisease specific conditions such as frailty and dementia 8 -may enhance existing risk prediction strategies for mortality within 1 year of ICD implantation. Frailty is the accumulation of insults across multiple organ systems that leads to decreased physiological reserves and resistance to stressors. 9 ICD research has focused on single-disease risk factors to identify patients likely to live at least 1 year after ICD implantation. Geriatric conditions may affect patient outcomes and clinical decision-making on the use of ICDs. Furthermore, specific patterns of coexisting conditions (as opposed to a simple tally of the number of conditions that an individual has) may synergistically lead to worsened outcomes. 10 However, little is known about the impact of geriatric conditions and patterns of comorbidity on 1-year mortality after ICD implantation.
Our objective was to determine the prevalence of comorbid conditions among older adults undergoing primary prevention ICD placement, with a focus on 2 common geriatric conditions: frailty and dementia. We also aimed to determine the impact of patterns of these geriatric conditions and other common comorbidities on mortality within 1 year of ICD implantation.
Methods

Sources of Data
We used data from the National Cardiovascular Data Registry (NCDR) ICD registry, which was created in 2006 in response to a mandate from the Centers for Medicare and Medicaid Services that required all hospitals to report data on primary prevention ICD implantations in Medicare patients. 4, 11 The registry contains patient demographics, cardiac history, comorbidities, type of device, and adverse events during the initial hospitalization. Implanting centers must enter complete and accurate data to receive Medicare reimbursement and the data undergo quality-control checks. 12 The present analysis used data from 2006 to the end of 2009.
Longitudinal outcomes were obtained by linking NCDR data with Medicare inpatient, outpatient, and carrier analytic files using probabilistic matching. 13 The inpatient files contain institutional claims for facility costs covered under Medicare Part A. The outpatient files contain claims from outpatient providers such as hospital outpatient departments, and the carrier files contain noninstitutional provider claims for services covered under Medicare Part B (eg, physicians and physician assistants).
Study Population
All new (not replacement) ICD implants from 2006 to 2009 were included. Patients were excluded if they were <65 years enrolled in Medicare Advantage or not enrolled in Medicare at the time of implantation; not enrolled in Medicare for a full year before implantation, did not have an ICD for primary prevention, did not have a history of heart failure, or had a previous ICD.
Geriatric Conditions: Dementia and Frailty
To be classified as having dementia, beneficiaries were required to have at least 1 Part A Medicare inpatient claim or 2 outpatient or carrier claims with International Classification of Diseases-Ninth Revision (ICD-9) codes 290.xx, 294.1x, or 331.2x. 14 We ascertained the presence of frailty using a coding algorithm designed for the Johns Hopkins Adjusted Clinical Groups (ACG) System (version 11), a tool that analyzes health insurance enrollment records and claims data to predict the intensity of a patient's future healthcare utilization. The ACG System is the most widely used population-based case mix system in the world. 15 The ACG System frailty marker incorporates 99 ICD-9 codes, selected by a group of geriatricians, and categorized into 10 clusters: malnutrition, dementia, severe vision impairment, decubitus ulcer, incontinence of urine, incontinence of feces, weight loss, social support needs, difficulty walking, and falls (Appendix I in the Data Supplement). 16, 17 The marker is a binary variable that identifies individuals as frail if they have one of the diagnostic clusters. It has been validated using the Medicare Current Beneficiary Survey and has been shown to accurately identify patients with limitations in activities of daily living. 16 
Chronic Conditions
Comorbid chronic conditions were ascertained first from the NCDR. We chose conditions that were (1) identifiable by either ICD-9 diagnosis codes or within the NCDR and (2) either prevalent among older adults or associated with mortality after receipt of an ICD. 18, 19 Diabetes mellitus, chronic obstructive pulmonary disease (COPD), renal disease (creatinine ≥2.0 or dialysis), cerebrovascular accident, and hyponatremia (serum sodium level <136) were identified in this manner. Comorbidities that were not identified in the NCDR were ascertained from Medicare data if they were present (as either the primary or a secondary diagnosis) on 1 Part A Medicare claim or 2 outpatient or carrier claims during the 365 days preceding the date of ICD implantation. Diagnoses were excluded if they were not present in the NCDR and were found on only 1 outpatient or carrier claim. This approach increases the specificity of diagnoses and eliminates rule out encounters. 20 We used validated ICD-9 coding algorithms for diabetes mellitus ( 
Patient Characteristics
We regressed death within 1 year after ICD implantation on the comorbidity clusters, with the group with no comorbidity as the reference group, adjusted for selected patient characteristics associated with mortality among primary prevention ICD recipients. These variables, obtained from the NCDR, included age, sex, most recent left ventricular ejection fraction, New York Heart Association classification, atrial fibrillation or flutter, and systolic blood pressure.
Primary Outcome
The outcome was death within 1 year after ICD implantation, determined from the Medicare Beneficiary Denominator data.
WHAT IS KNOWN
• Implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death are not recommended for patients with a life expectancy <1 year. • ICD research has focused on single-disease risk factors to identify patients likely to live at least 1 year after ICD implantation.
WHAT THE STUDY ADDS
• More than 10% of patients receiving primary prevention ICDs are frail or have dementia. Frailty and dementia are more strongly associated with mortality within the first year after ICD implantation than are traditional comorbidities. • The high 1-year mortality rate among patients with frailty and dementia undergoing ICD implantation should be incorporated into the highly preferencesensitive decision of whether to implant an ICD for primary prevention.
Statistical Analysis
First, we determined the prevalence and 1-year mortality rate of each of the traditional comorbidities and of frailty and dementia, the geriatric conditions of interest. To determine the impact of multimorbidity patterns on 1-year mortality, we used a stepwise multimorbidity pattern analysis technique that has been previously described. 10, 23, 24 The first step was to specify our list of building block conditions. We used 7 chronic conditions and the 2 geriatric conditions described above.
Next, we sought to determine the most prevalent multimorbidity patterns. A multimorbidity pattern is a specific, mutually exclusive combination of building block conditions, such as dementia and COPD. In a multimorbidity pattern analysis, individuals are sorted into mutually exclusive patterns using logic rules. Because 9 conditions were initially considered, a large number of patterns were derived; however, most of the patterns included few individuals. Prevalence was estimated for each of the 275 mutually exclusive patterns of conditions (all single-disease occurrences and all combinations of ≥2 conditions).
The association of each multimorbidity pattern with 1-year mortality after ICD implantation was then estimated using logistic regression models unadjusted and adjusted for selected patient characteristics. The initial pattern table was sorted from highest to lowest by (1) prevalence and (2) 1-year mortality. The next phase involved identifying a reduced number of co-occurring conditions to include in the final pattern analysis. Three geriatricians (A.R.G., B.L., and D.D.M.) adjudicated all 275 patterns and combined them into a reduced number of clinically meaningful, mutually exclusive patterns. This process was iterative and was guided by clinical experience in addition to the prevalence and mortality data.
Odds ratios (ORs) were modeled for 1-year mortality in ICD recipients aged ≥65 with heart failure plus a multimorbidity pattern versus heart failure alone. The effects of covariates were examined through multivariate models. To address the large number of multiple comparisons, we evaluated significance at the P<0.001 level. Analyses were performed using the SAS statistical package version 9.2 (SAS Institute, Cary, NC). All analyses were approved by the Yale University Human Investigation Committee.
Results
Patient Characteristics
From January 2006 to December 2009, 188 020 ICDs were implanted in patients ≥65 years ( Figure 1 ). Patients were excluded if they were not in Medicare at the time of implantation (n=6434; 3%), not in Medicare for a full year before implantation (n=8936; 5%), received an ICD for secondary prevention (n=36 983; 21%), did not have a history of heart failure (n=21 365; 16%), or had a previous ICD (n=30 510; 27%). The final study cohort included 83 792 patients in 1314 hospitals (73% of the initial sample).
Characteristics of the 83 792 patients are listed in the Table. The mean patient age was 75.42 (6.08) years. Most patients were men (72%) and white (85%). One third of the patients had an left ventricular ejection fraction <20% (this cutoff was chosen because patients with a 20% 1-year mortality risk do not clearly benefit from ICDs), 1,2 and 92% had New York Heart Association Class II or III heart failure.
Geriatric Conditions and Chronic Conditions
The absence of all diseases other than heart failure was the most common pattern (19%). Overall, 10% of patients with ICDs were frail and 1% had dementia. The prevalence of comorbid chronic conditions was 47% for diabetes mellitus, 35% for COPD, 27% for cerebrovascular accident, 26% for chronic kidney disease, and 19% for hyponatremia.
Metastatic solid tumor and cirrhosis each accounted for <1% of the population.
Mortality
The overall 1-year mortality after ICD implantation was 12%. Geriatric conditions were highly associated with mortality within 1 year of ICD implantation. A total of 27% of patients with dementia died within the first year and 22% of patients with frailty. Of the traditional comorbidities, only metastatic solid tumor and cirrhosis had 1-year mortality rates comparable with dementia. Chronic kidney disease had a higher 1-year mortality (23%) than frailty. Hyponatremia, diabetes mellitus, COPD, and cerebrovascular accident all had lower 1-year mortality rates than dementia and frailty ( Figure 2 ). Among patients with no conditions other than heart failure, 4% died within the first year.
In multimorbidity patterns analysis, 11 mutually exclusive patterns were examined ( Figure 3 ). Several multimorbidity patterns had 1-year mortality rates after ICD implantation >20%: dementia with frailty (29%), frailty with COPD (25%), and frailty with diabetes mellitus (23%). These 3 patterns together accounted for 8% of patients. Patients with both frailty and dementia had the highest odds of death when compared with patients with no comorbidity (OR, 8.68; 95% confidence interval [CI], 7.33-10.27; Figure 4 ). Dementia and frailty consistently elevated the risk of death from a patient's traditional comorbidities. For example, patients with frailty and diabetes mellitus (the most prevalent coexisting chronic condition in the cohort) were 6× as likely to die within 1 year of ICD implantation than people with heart failure alone (OR, 6.49; 95% CI, 5.81-7.24). In contrast, patients with diabetes mellitus who were not frail were nearly 4× as likely to die within 1 year of ICD implantation (OR, 3.60; 95% CI, 3.30-3.92). A similar pattern was found for the combination of COPD and frailty.
In total, 17% of implants were upgrades from pacemakers to ICDs. As upgrade procedures have been associated with greater risk of complications, 25 we performed a sensitivity analysis to examine the extent to which this may have contributed to our results. Incorporating previous pacemaker as a covariate in the multivariate analyses did not alter our findings. Two multimorbidity patterns were associated with higher rates of in-hospital complications or death after ICD implantation, COPD (OR, 1.21; 95% CI, 1.08-1.35) and frailty with COPD (OR, 1.35; 95% CI, 1.08-1.69).
Discussion
The main finding of this study is that >10% of patients receiving primary prevention ICDs are frail or have dementia.
Patients with these geriatric conditions had substantially higher mortality within the first year after ICD implantation than those without these conditions. Several multimorbidity patterns were associated with high 1-year mortality rates: dementia with frailty, frailty with COPD, and frailty with diabetes mellitus. Frailty and dementia were more strongly associated with mortality than were traditional comorbidities.
To our knowledge, this is the first study to determine the prevalence of frailty among older adults receiving primary prevention ICDs. We identified frail patients using an algorithm designed for use with Medicare claims. Analyses of large claims databases can advance the evidence base on ICD therapy, geriatric conditions, and treatment effect heterogeneity. Several studies have shown that frailty is independently associated with mortality among older adults with heart failure, and that frailty assessment may identify patients at risk of poor outcomes after invasive procedures. [26] [27] [28] [29] For older adults with multiple coexisting illnesses, ICD therapy may make life and death more onerous through postprocedural complications, increased hospitalizations, inappropriate shocks, and futile end-of-life shocks among patients dying of nonarrhythmic causes. 30 Viewed in this context, our findings point toward a greater role for frailty screening among older adults who are being considered for primary prevention ICDs based on cardiac criteria. Frailty screening may improve appropriate ICD utilization and patient outcomes.
Our study also confirms the importance of dementia for short-term mortality outcomes after ICD implantation. Previous research has shown that 6% of patients hospitalized for heart failure have dementia, and that the use of ICDs to prevent sudden cardiac death would provide limited benefit among such patients. 31 Another study demonstrated that the 5-year survival of patients with cognitive impairment or dementia who underwent pacemaker or ICD insertion was significantly lower than that of matched controls without cognitive impairment or dementia. 32 In our study, patients with dementia who underwent ICD implantation had a 1-year mortality rate comparable with that of patients with metastatic solid tumors. Although the 1-year mortality rates for these 2 conditions were clinically similar, they were statistically different because of our large sample size. We found that dementia was present in only 1% of Medicare beneficiaries undergoing primary prevention ICD placement. This suggests that physicians referring patients for ICD implantation may already be identifying patients with significant cognitive impairment who are likely to derive limited benefit from ICDs.
Traditional multivariate regression does not account for the specific patterns of co-occurring conditions prevalent among older adults with heart failure. Previous studies used comorbidity indices such as the Charlson to examine multimorbidity in older adults with ICDs. 18 However, the Charlson is difficult to use in clinical practice. Furthermore, such indices were not developed in older adults with heart failure, and conditions that may have the most bearing on outcomes, such as frailty and dementia, are not incorporated or not appropriately weighted. Clinicians do not treat Charlson scores; they treat individuals. We used a stepwise multimorbidity pattern analysis technique to gain an in-depth understanding of the comorbidity burden of older adults with heart failure, ICDs, dementia, and frailty. We sorted the 275 mutually exclusive patterns of conditions by prevalence and 1-year mortality, and then combined patterns into mutually exclusive groups. This revealed that the combination of frailty and another comorbidity signified a state of heightened vulnerability after ICD implantation. For example, 23% of patients with frailty and diabetes mellitus died within 1 year of ICD implantation compared with 13% of patients who had diabetes mellitus but were not frail. Several multimorbidity patterns had 1-year mortality rates after ICD implantation >20%: dementia with frailty, frailty with COPD, and frailty with diabetes mellitus. This finding is important because it is not clear that ICD therapy benefits patients with a ≥20% baseline annual mortality risk. 2, 33 Retrospective studies that used data from the primary prevention trials found that patients with a predicted annual mortality ≥20% (using risk prediction tools such as the Seattle Heart Failure Model) did not seem o benefit from ICD therapy. The development of risk prediction models to identify patients who are unlikely to benefit from ICDs is an active area of investigation. We do not yet know the best method of identifying patients with high 1-year mortality risk who are unlikely to benefit from ICD therapy. Furthermore, older adults with multiple comorbidities were under-represented in the primary prevention trials, underscoring the challenge of generalizing the results to the large numbers of older adults receiving ICDs. Our study adds to the literature by taking a clinically relevant approach to examining multimorbidity in older adults with ICDs, and making risk prediction relevant to older adults with multiple comorbidities and geriatric conditions. Current guidelines for the use of primary prevention ICDs, including guidelines for the care of vulnerable older adults with heart failure, have not incorporated assessment of frailty. 8, 34, 35 Our analysis suggests additional elements to include in the National ICD Registry data collection process, such as a physical performance test, measurement of gait speed, or composite frailty scale. These data are already being collected from patients undergoing aortic valve replacement and cardiac surgery. 36 Our findings highlight the need for subsequent studies involving detailed clinical assessments of frailty among older Because our sorting and ranking step had confirmed that many of the patterns with high 1-year mortality included frailty or dementia, and because these were the geriatric conditions of interest, we first classified patients into a multimorbidity pattern based on the presence of 1 of these 2 geriatric conditions. Patients who did not have dementia or frailty were placed into another multimorbidity pattern based on their individual combination of building block conditions. †Each row is a distinct pattern. Shading identifies which comorbidities comprise the pattern. Each pattern does include the comorbidity shaded in black and may include any of the other comorbidities in that row shaded in gray. For example, all individuals represented in row 2 have dementia, but any individual in row 2 may also have the conditions shaded in gray. Individuals in row 7 have either cirrhosis, metastatic solid tumor, hyponatremia, or a combination of these 3 comorbidities and no others. ‡CKD indicates chronic kidney disease; COPD = chronic obstructive pulmonary disease; and CVA, cerebrovascular disease.
adults being considered for primary prevention ICD therapy. Identification of geriatric conditions should improve risk prediction and foster patient-centered clinical decision making. Future primary prevention ICD eligibility guidelines should incorporate frailty and dementia. In addition, frailty assessment should be taught as a part of training and recertification for implanting physicians and general cardiologists who are likely to refer patients for ICDs. Our findings should be interpreted in the context of some limitations. The main drawback is the lack of a consensus on how frailty should be evaluated. The claim-based algorithm we used to identify clinically frail patients has been used in 2 other studies, but it has not been tested in a heart failure population. 16, 17 Although there is no gold standard for the assessment of frailty, numerous definitions have been proposed. The Fried frailty phenotype is the most widely used. It is standardized, physiologically based, and independently predicts adverse outcomes such as falls, hospitalizations, and death in older adults. Using this definition, 6.9% of older adults in the Cardiovascular Health Study were identified as frail. 9 Adaptations of this clinical phenotype abound. Rockwood's Frailty Index operationalizes frailty as the number of accumulated deficits; among a sample of elderly Canadians, 22.7% were identified as frail using the Frailty Index. 37 Still others propose using solitary objective measures, such as gait speed, as a proxy for frailty. 38 In the present study, use of the ACG System frailty measure was motivated by the available data and was intended to be hypothesis generating rather than definitive. Patients may have been classified as frail as a consequence of heart failure alone. It was beyond the scope and aims of our study to determine whether certain clusters, such as falls or incontinence, were more prevalent among patients identified as frail. It is unlikely that urinary incontinence is synonymous with frailty, or that social support needs can be accurately measured in administrative claims. We recognize that these are inherent problems with the frailty marker we used. However, despite these qualifications, our use of the ACG System frailty measure had face validity because we identified a subset of previously unrecognized patients with heightened vulnerability, as evidenced by their 22% mortality in the first year after ICD implantation. These findings are novel and clinically significant. We did not have data on the cause of death and therefore cannot say whether patients identified as frail using our measure died as a result of causes unrelated to the ICD; this is an important avenue for future research.
The proportion of ICD recipients who had frailty was much higher than the proportion who had dementia. Frail older adults should not be excluded a priori from ICD implantation, and we cannot say what the correct rate of ICD implantation among frail older adults should be. We were unable to determine the benefit (or lack thereof) of ICDs in frail patients because the available data only allowed us compare outcomes among patients who all received the device. But the high 1-year mortality rate among patients with frailty undergoing ICD implantation should be incorporated into the highly preference-sensitive decision of whether to implant an ICD for primary prevention. Our finding that primary prevention ICD recipients with frailty have high 1-year mortality is crucial information for patients and clinicians to have in the shared decision-making process. Future research should confirm the significance of our findings by prospectively evaluating clinical measures of frailty among patients with ICDs, and comparing quality of life and clinical outcomes for ICD-eligible patients with dementia and frailty who either do or do not receive an ICD.
Another limitation is that we have probably underestimated the true prevalence of dementia among ICD recipients because dementia is undercoded in Medicare claims data. 39 Dementia, as identified in claims, is often advanced. We do not intend to imply that there is a correct rate of ICD implantation in patents with dementia; it probably should not be zero. Rather, we hope our findings will support meaningful, patient-centered discussions about ICD implantation between physicians, older adults with cognitive impairment, and their families.
Our analysis of geriatric conditions was limited to frailty and dementia. We chose these conditions because they could be identified using ICD-9 codes. However, other geriatric conditions, such as polypharmacy, may play an important role in modifying patient outcomes after receipt of an ICD. In addition, the available data did not enable us to examine the influence of geriatric conditions on other outcomes that may be valued by older adults with ICDs, such as functional status and quality of life. Finally, although we restricted the cohort to primary prevention patients, an appreciable number had a history of ventricular tachycardia (25%; primarily nonsustained) and New York Heart Association class IV heart failure (5%). The inclusion of these patients, who were likely to be sicker, may have affected our findings. Importantly, however, these data reflect real-world use of ICDs. Despite these limitations, our study is an important first step in establishing the prognostic importance of geriatric conditions, particularly frailty, in older adults undergoing ICD implantation. There is growing awareness of the need for a more comprehensive approach to clinical decision making on the use of recent innovations in heart failure management, such as ICDs, transcatheter aortic valve replacements, and left ventricular assist devices. Decision making on the use of recent innovations in heart failure management must go beyond individual diseases and consider geriatric conditions, as well as the context of the patient. 8 Future research should confirm the influence of frailty on patient outcomes after ICD implantation using different frailty measures, explore patient-centered outcomes in addition to mortality, and test frailty assessment tools that can be implemented in a heart failure clinic.
